Significance of HSD17B1 in breast and ovarian cancer - validation of novel HSD17B1 antibodies
| dc.contributor.author | Kivikoski, Titta | |
| dc.contributor.department | fi=Biolääketieteen laitos|en=Institute of Biomedicine| | - |
| dc.contributor.faculty | fi=Lääketieteellinen tiedekunta|en=Faculty of Medicine| | - |
| dc.contributor.studysubject | fi=Terveyden biotieteet|en=Health Biosciences| | - |
| dc.date.accessioned | 2017-10-04T11:52:42Z | |
| dc.date.available | 2017-10-04T11:52:42Z | |
| dc.date.issued | 2017-10-04 | |
| dc.format.content | abstractOnly | - |
| dc.identifier.olddbid | 160536 | |
| dc.identifier.oldhandle | 10024/143930 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/5008 | |
| dc.language.iso | eng | - |
| dc.publisher | fi=Turun yliopisto|en=University of Turku| | - |
| dc.source.identifier | https://www.utupub.fi/handle/10024/143930 | |
| dc.title | Significance of HSD17B1 in breast and ovarian cancer - validation of novel HSD17B1 antibodies | - |
| dc.type.ontasot | fi=Pro gradu -tutkielma|en=Master's thesis| | - |
Tiedostot
1 - 1 / 1
Ladataan...
- Name:
- Kivikoski Titta.pdf
- Size:
- 52.63 KB
- Format:
- Adobe Portable Document Format
- Description:
- Tiivistelmä